Telix Pharmaceuticals Ltd

NEW
OTCPK:TLPPF (Australia)   Ordinary Shares
$ 11.88 +0.70 (+6.31%) 12:57 PM EST
At Loss
P/B:
9.81
Market Cap:
$ 4.12B
Enterprise V:
$ 4.44B
Volume:
4.16K
Avg Vol (2M):
5.63K
Trade In:
Volume:
4.16K
At Loss
Avg Vol (2M):
5.63K

Telix Pharmaceuticals Ltd’s share price is $11.875. Its GF Value is $28.45. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Telix Pharmaceuticals Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: $11.875 GF Value Price/GF Value
Current $28.45 0.42
Next FY1 End $31.14 0.38
Next 12 Month $34.1 0.35
Next FY2 End $36.24 0.33
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Telix Pharmaceuticals Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Telix Pharmaceuticals Ltd's stock price and Earnings without NRI per share, with a coefficient of 82%. This is followed by a 80% correlation with Book Value per share and a 79% correlation with Revenue per share. The weakest correlation is observed with Revenue per share, at 70%.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies